Researcher.Life Logo

Human and Experimental Toxicology : Impact Factor & More

eISSN: 1477-0903pISSN: 0960-3271

Aims and Scope of Human and Experimental Toxicology

Human & Experimental Toxicology is a peer-reviewed medical journal covering the field of toxicology. It was established in 1981 as Human Toxicology and obtained its current name in 1990. It is published by SAGE Publications and the editor-in-chief is Kai Savolainen (Finnish Institute of Occupational Health). Less

Key Metrics

CiteScore
4.3
Impact Factor
< 5
SJR
Q2Toxicology
SNIP
0.89
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Human and Experimental Toxicology

Human and Experimental Toxicology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1990
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Human and Experimental Toxicology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Human and Experimental Toxicology

TRIM37 mitigates adriamycin-induced nephropathy by promoting PTEN ubiquitination and degradation to suppress mitochondrial apoptosis and podocyte injury
  • 1 Mar 2026
  • Human &amp; Experimental Toxicology
Retraction: Protection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain
  • 1 Mar 2026
  • Human &amp; Experimental Toxicology
Reactive oxygen species-mediated epidermal stress in human keratinocytes under dual exposure to blue light and heated tobacco product
  • 11 Feb 2026
  • Human &amp; Experimental Toxicology
Alleviation of the mitochondrial dynamics impairment in doxorubicin-induced cardiomyocyte toxicity by cardioprotective agents
  • 1 Feb 2026
  • Human &amp; Experimental Toxicology
Curculigoside attenuates cerebral ischemia-reperfusion injury via TRPM2-mediated microglial polarization
  • 1 Feb 2026
  • Human &amp; Experimental Toxicology
Corrigendum to “Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-κB pathways”
  • 1 Feb 2026
  • Human &amp; Experimental Toxicology
TRIM37 mitigates adriamycin-induced nephropathy by promoting PTEN ubiquitination and degradation to suppress mitochondrial apoptosis and podocyte injury
  • 1 Mar 2026
  • Human &amp; Experimental Toxicology
Retraction: Protection by pentoxifylline of malathion-induced toxic stress and mitochondrial damage in rat brain
  • 1 Mar 2026
  • Human &amp; Experimental Toxicology
Reactive oxygen species-mediated epidermal stress in human keratinocytes under dual exposure to blue light and heated tobacco product
  • 11 Feb 2026
  • Human &amp; Experimental Toxicology
Alleviation of the mitochondrial dynamics impairment in doxorubicin-induced cardiomyocyte toxicity by cardioprotective agents
  • 1 Feb 2026
  • Human &amp; Experimental Toxicology
Curculigoside attenuates cerebral ischemia-reperfusion injury via TRPM2-mediated microglial polarization
  • 1 Feb 2026
  • Human &amp; Experimental Toxicology
Corrigendum to “Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-κB pathways”
  • 1 Feb 2026
  • Human &amp; Experimental Toxicology

FAQs on Human and Experimental Toxicology